Cargando…

OR16-06 A Novel Pathway Controlling Anticancer Drug Induced Immunogenic Necrosis In ERα Positive Cancer Cells

Disclosure: J. Zhu: None. S. Ghosh: None. D. Duraki: None. M. Boudreau: Other; Self; Patent on ErSO. M. Jabeen: None. C. Mao: None. B. Park: None. G. Cheng: None. E.R. Nelson: None. P.J. Hergenrother: Advisory Board Member; Self; System Oncology. Other; Self; Patent on ErSO. D.J. Shapiro: Other; Sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Junyao, Ghosh, Santanu, Duraki, Darjan, Boudreau, Matthew, Jabeen, Musarrat, Mao, Chengjian, Park, Ben Ho, Cheng, Georgina, Nelson, Erik Russell, Hergenrother, Paul J, Shapiro, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554699/ http://dx.doi.org/10.1210/jendso/bvad114.2198

Ejemplares similares

OR16-1 How Strong and Sustained Activation of the Estrogen Receptor-mediated Anticipatory Unfolded Protein Response Kills Breast and Ovarian Cancer Cells
por: Boudreau, Matthew, et al.
Publicado: (2022)

OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2020)

ERa-Dependent Lethal Hyperactivation of the Anticipatory Unfolded Protein Response Induces Complete Regression Without Recurrence of Advanced Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2021)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
por: Nam, Gi-Hoon, et al.
Publicado: (2021)

OR27-06 Identification And Functional Analyses Of Therapeutic Targets For Testicular Germ Cell Tumors
por: Horie, Kuniko, et al.
Publicado: (2023)

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

RARE-06. OPTIMIZATION OF PROTON RADIATION THERAPY FOR GIANT CRANIOPHARYNGIOMAS
por: Flores, Valerie Cruz, et al.
Publicado: (2020)

RARE-06. Expanding the clinical and molecular spectrum of pituitary blastoma
por: Pak-Yin Liu, Anthony, et al.
Publicado: (2022)

EMBR-06. EFFECTIVE INHIBITION OF MYC-AMPLIFIFIED GROUP 3 MEDULLOBLASTOMA BY FACT-TARGETED CURAXIN DRUG CBL0137
por: Wang, Jiajia, et al.
Publicado: (2021)

OR05-06 Histone Deacetylase Inhibitor, Panobinostat, In Combination With A Smac-mimetic For The Treatment Of Ovarian Granulosa Cell Tumours
por: Chu, Simon, et al.
Publicado: (2023)

THU559 3D Immuno-smFISH Reveals ER-responsive Cells At The Single-cell Level In ER(+) Breast Cancer
por: Kammel, Laura G, et al.
Publicado: (2023)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

ODP562 ZnT5 Involvement in EMT in Breast Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2022)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

RARE-06. DISSECTING CELLULAR DIFFERENTIATION HETEROGENEITY IN CHOROID PLEXUS CARCINOMA PATHOGENESIS
por: Faltings, Lukas, et al.
Publicado: (2023)

ODP539 AIPB is a Biomarker for ER+/PR+/Her2- Breast Cancers
por: Cubbedge, Chandler, et al.
Publicado: (2022)

ETMR-06. DISSECTING THE MOLECULAR AND DEVELOPMENTAL BASIS OF PINEOBLASTOMA THROUGH GENOMICS
por: Gudenas, Brian, et al.
Publicado: (2020)

SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer
por: Olukoya, Ayodeji O, et al.
Publicado: (2020)

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer
por: Truong, Thu Ha, et al.
Publicado: (2021)

RARE-06. CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)
por: Yang, Xiaoqin, et al.
Publicado: (2021)

THU555 Stress Induced AIPB Expression In Triple Negative (ER-/PR-/Her2-) Breast Tumors Reduces Estradiol
por: Patrawala, Mahjabin, et al.
Publicado: (2023)

Cellular cytotoxicity is a form of immunogenic cell death
por: Minute, Luna, et al.
Publicado: (2020)

Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
por: Wang, Yan, et al.
Publicado: (2020)

OR16-04 Androgen Deprivation Restricts Anti-tumor Immunity In Adrenocortical Carcinoma
por: Warde, Kate M, et al.
Publicado: (2023)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

GCT-06. DIAGNOSIS OF A RARE CASE OF RECURRENT GERM CELL TUMOR BY CSF PLACENTAL ALKALINE PHOSPHATASE PRESENTING WITH DIFFUSE INTRAAXIAL ABNORMALITY IN THE LOWER BRAINSTEM
por: Yamada, Hiroki, et al.
Publicado: (2020)

Local anesthetics elicit immune-dependent anticancer effects
por: Bezu, Lucillia, et al.
Publicado: (2022)

Loss of secreted gelsolin enhances response to anticancer therapies
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2022)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

OR16-02 Histone ADP-Ribosylation Site Mutations As Oncogenic Drivers In Breast And Ovarian Cancers
por: Huang, Dan, et al.
Publicado: (2023)

OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy
por: Vidana Gamage, Hashni Epa, et al.
Publicado: (2023)

OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer
por: Truong, Thu H, et al.
Publicado: (2020)

OR16-01 A Common WNT4 Polymorphism Drives Gynecologic Cancer Phenotypes And Health Disparities
por: Bitler, Benjamin G, et al.
Publicado: (2023)

EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
por: Daggubati, Vikas, et al.
Publicado: (2021)

ETMR-06. Molecular and clinical characteristics of CNS tumors withBCOR(L1) fusion/internal tandem duplication
por: Gojo, Johannes, et al.
Publicado: (2022)

OR16-03 Epigenetic Studies Of Pancreatic Neuroendocrine Tumours (PNETs) Reveal Decreased DNA Hydroxymethylation In Non-functioning PNETs But Not Insulinomas
por: English, Katherine A, et al.
Publicado: (2023)

ATRT-06. Atypical Teratoid Rhabdoid Tumors (ATRT): results from a Single Institution in Brazil - São Paulo University
por: Barreto, Juliana Silveira, et al.
Publicado: (2022)

Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway
por: Zhang, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ea2crupf2luvc0dmuliledk4sf